Horizon Pharma plc

Connaught House, 1st Floor,
Dublin, 4
Ireland,
353 1 772 2100
www.horizonpharma.com

Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon’s global headquarters are in Dublin, Ireland.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (1.6/yr) # - 1 2 2 2 1 8
vol $705M $1.6B $828M $145M $3.3B
Sell (0.2/yr) # - - - - - 1 1
vol $70M $70M
  9

Top M&A Advisors

Financial Deals
Sign-up to View
3
Sign-up to View
3
Sign-up to View
2
Legal Deals
Sign-up to View
4
Sign-up to View
3
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Hyperion Therapeutics, Inc.
$1.1B (2015-04-03)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Raptor Pharmaceuticals Corp.
$70M (2017-05-23)

According to our data here at Mergr, Horizon Pharma has acquired 9 companies, including 9 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 1 asset.

Horizon Pharma’s largest acquisition to date was in 2015, when it acquired Hyperion Therapeutics for $1.1B. It’s largest disclosed sale occurred in 2017, when it sold Raptor Pharmaceuticals to Chiesi Farmaceutici for $70M. Horizon Pharma has acquired in 5 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 415 life science companies that have made at least 1 acquisition, 24 have acquired at least 5 companies, and 3 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 25 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Horizon Pharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.